Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS GLAND PHARMA RAYMED LABS/
GLAND PHARMA
 
P/E (TTM) x -7.1 46.0 - View Chart
P/BV x - 3.8 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   GLAND PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
GLAND PHARMA
Mar-23
RAYMED LABS/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs23,556 0.1%   
Low Rs11,130 0.1%   
Sales per share (Unadj.) Rs0214.5 0.0%  
Earnings per share (Unadj.) Rs-0.447.5 -0.8%  
Cash flow per share (Unadj.) Rs-0.456.5 -0.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-5.4484.3 -1.1%  
Shares outstanding (eoy) m4.27164.30 2.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x010.9-  
Avg P/E ratio x-4.449.3 -8.9%  
P/CF ratio (eoy) x-4.641.5 -11.0%  
Price / Book Value ratio x-0.34.8 -6.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m8385,002 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m04,033 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m035,245 0.0%  
Other income Rs m02,405 0.0%   
Total revenues Rs m037,650 0.0%   
Gross profit Rs m-29,683 -0.0%  
Depreciation Rs m01,467 0.0%   
Interest Rs m074 0.0%   
Profit before tax Rs m-210,546 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m02,735 0.0%   
Profit after tax Rs m-27,810 -0.0%  
Gross profit margin %027.5- 
Effective tax rate %025.9 -0.0%   
Net profit margin %022.2- 
BALANCE SHEET DATA
Current assets Rs m069,008 0.0%   
Current liabilities Rs m17,291 0.0%   
Net working cap to sales %0175.1- 
Current ratio x0.19.5 0.6%  
Inventory Days Days013- 
Debtors Days Days090- 
Net fixed assets Rs m218,767 0.0%   
Share capital Rs m43165 26.0%   
"Free" reserves Rs m-6679,406 -0.1%   
Net worth Rs m-2379,571 -0.0%   
Long term debt Rs m033 0.0%   
Total assets Rs m287,775 0.0%  
Interest coverage x0142.6-  
Debt to equity ratio x00 -0.0%  
Sales to assets ratio x00.4 0.0%   
Return on assets %-109.59.0 -1,218.7%  
Return on equity %7.49.8 75.5%  
Return on capital %7.413.3 55.5%  
Exports to sales %086.8-  
Imports to sales %00-  
Exports (fob) Rs mNA30,590 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m030,590 0.0%   
Fx outflow Rs m017,819 0.0%   
Net fx Rs m012,771 0.0%   
CASH FLOW
From Operations Rs m-23,640 -0.0%  
From Investments Rs m212,082 0.0%  
From Financial Activity Rs mNA149 0.0%  
Net Cashflow Rs m015,901 -0.0%  

Share Holding

Indian Promoters % 28.4 0.0 -  
Foreign collaborators % 0.0 57.9 -  
Indian inst/Mut Fund % 1.0 28.2 3.4%  
FIIs % 0.0 4.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 42.1 170.0%  
Shareholders   1,498 136,021 1.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RAYMED LABS. vs GLAND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs GLAND PHARMA Share Price Performance

Period RAYMED LABS. GLAND PHARMA S&P BSE HEALTHCARE
1-Day 0.00% 1.09% 1.29%
1-Month 3.32% 2.25% -0.64%
1-Year 6.86% 46.26% 62.00%
3-Year CAGR 31.90% -9.65% 18.20%
5-Year CAGR -1.90% 0.21% 19.81%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the GLAND PHARMA share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of GLAND PHARMA the stake stands at 57.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of GLAND PHARMA.

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

GLAND PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of GLAND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.